PL2744571T3 - Sposób hamowania adipogenezy za pomocą kompozycji zawierającej scirpusynę a i scirpusynę b i potencjał przeciwotyłościowy scirpusyny a i scirpusyny b - Google Patents

Sposób hamowania adipogenezy za pomocą kompozycji zawierającej scirpusynę a i scirpusynę b i potencjał przeciwotyłościowy scirpusyny a i scirpusyny b

Info

Publication number
PL2744571T3
PL2744571T3 PL13819890T PL13819890T PL2744571T3 PL 2744571 T3 PL2744571 T3 PL 2744571T3 PL 13819890 T PL13819890 T PL 13819890T PL 13819890 T PL13819890 T PL 13819890T PL 2744571 T3 PL2744571 T3 PL 2744571T3
Authority
PL
Poland
Prior art keywords
scirpusin
obesity potential
obesity
potential
Prior art date
Application number
PL13819890T
Other languages
English (en)
Inventor
Douglas KALMAN
Beena Bhat
Priti VAIDYANATHAN
Sarang Bani
Anjali Pandey
Muhammed Majeed
Kalyanam Nagabhushanam
Original Assignee
Muhammed Majeed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Muhammed Majeed filed Critical Muhammed Majeed
Publication of PL2744571T3 publication Critical patent/PL2744571T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/89Cyperaceae (Sedge family)
    • A61K36/8905Cyperus (flatsedge)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL13819890T 2012-07-18 2013-07-17 Sposób hamowania adipogenezy za pomocą kompozycji zawierającej scirpusynę a i scirpusynę b i potencjał przeciwotyłościowy scirpusyny a i scirpusyny b PL2744571T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261672849P 2012-07-18 2012-07-18
EP13819890.8A EP2744571B1 (en) 2012-07-18 2013-07-17 Scirpusin a and scirpusin b and anti-obesity potential thereof
PCT/US2013/050940 WO2014015067A2 (en) 2012-07-18 2013-07-17 Composition comprising scirpusin a and scirpusin b anti-obesity potential thereof

Publications (1)

Publication Number Publication Date
PL2744571T3 true PL2744571T3 (pl) 2020-04-30

Family

ID=49947067

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13819890T PL2744571T3 (pl) 2012-07-18 2013-07-17 Sposób hamowania adipogenezy za pomocą kompozycji zawierającej scirpusynę a i scirpusynę b i potencjał przeciwotyłościowy scirpusyny a i scirpusyny b
PL16184143T PL3108935T3 (pl) 2012-07-18 2013-07-17 Kompozycja zawierająca scirpusynę a i scirpusynę b oraz jej potencjał przeciw otyłości

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL16184143T PL3108935T3 (pl) 2012-07-18 2013-07-17 Kompozycja zawierająca scirpusynę a i scirpusynę b oraz jej potencjał przeciw otyłości

Country Status (11)

Country Link
US (1) US9387193B2 (pl)
EP (2) EP2744571B1 (pl)
JP (1) JP6135761B2 (pl)
KR (2) KR101717889B1 (pl)
AU (1) AU2013292593B2 (pl)
CA (1) CA2883176C (pl)
EA (1) EA025578B1 (pl)
NZ (1) NZ622927A (pl)
PH (1) PH12015500349B1 (pl)
PL (2) PL2744571T3 (pl)
WO (1) WO2014015067A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016178716A1 (en) 2015-05-06 2016-11-10 Muhammed Majeed Composition comprising scirpusin a and scirpusin b and anti-obesity potential thereof
CN104910172B (zh) * 2015-06-24 2017-07-11 辽宁中医药大学 五种二苯乙烯三聚体的制备方法及其应用
WO2021146651A1 (en) * 2020-01-17 2021-07-22 Muhammed Majeed Process and compositions for enhancing energy expenditure
CN112666277B (zh) * 2020-11-30 2022-07-08 四川新绿色药业科技发展有限公司 一种香附药材、饮片、标准汤剂、配方颗粒hplc特征图谱的构建及检测方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8017634B2 (en) * 2003-12-29 2011-09-13 President And Fellows Of Harvard College Compositions for treating obesity and insulin resistance disorders
US20060110479A1 (en) * 2004-11-24 2006-05-25 Mitra Shankar K Natural composition for curing hepatitis-B, methods for making the same and pharmaceutical formulations thereof
KR20080050794A (ko) * 2006-12-04 2008-06-10 장용훈 복합 생약 추출물(mst)을 함유하는 비만의 예방 및치료용 조성물
CN101274050B (zh) * 2007-03-28 2011-05-18 复旦大学 荆三棱在制备治疗艾滋病药物中的用途
WO2011033524A2 (en) * 2009-08-04 2011-03-24 Laila Nutraceuticals Agents from ficus hispida for the amelioration of metabolic syndrome and related diseases
KR20110087808A (ko) * 2010-01-27 2011-08-03 이경준 복합 생약추출물을 함유하는 비만의 예방과 치료용 조성 물질의 개발 및 체질별 간 기능 개선, 중성지방 저하를 동시에 치료하는 조성물 개발
KR101188581B1 (ko) * 2010-06-09 2012-10-05 동국대학교 경주캠퍼스 산학협력단 향부자 메탄올 추출물을 유효성분으로 함유하는 패혈증 예방 또는 치료용 조성물
US20120029085A1 (en) * 2010-07-29 2012-02-02 Mackay Jon Stabilization of quinol composition such as catecholamine drugs

Also Published As

Publication number Publication date
PL3108935T3 (pl) 2020-10-05
PH12015500349A1 (en) 2015-04-20
JP2015527324A (ja) 2015-09-17
CA2883176C (en) 2020-12-01
KR101600212B1 (ko) 2016-03-04
PH12015500349B1 (en) 2015-04-20
EA025578B1 (ru) 2017-01-30
EA201490752A1 (ru) 2016-05-31
EP2744571A4 (en) 2015-10-21
WO2014015067A2 (en) 2014-01-23
AU2013292593A8 (en) 2014-05-01
EP2744571A2 (en) 2014-06-25
EP3108935A1 (en) 2016-12-28
AU2013292593A1 (en) 2014-04-17
EP3108935B1 (en) 2020-04-22
NZ622927A (en) 2017-03-31
KR20160018878A (ko) 2016-02-17
AU2013292593B2 (en) 2018-04-26
WO2014015067A3 (en) 2014-04-10
EP2744571B1 (en) 2019-10-16
JP6135761B2 (ja) 2017-05-31
US9387193B2 (en) 2016-07-12
CA2883176A1 (en) 2014-01-23
KR101717889B1 (ko) 2017-03-17
KR20140065438A (ko) 2014-05-29
US20140024706A1 (en) 2014-01-23
WO2014015067A4 (en) 2014-05-30

Similar Documents

Publication Publication Date Title
IL269045A (en) Aptamars and their uses
HK1202545A1 (en) New diazaspirocycloalkane and azaspirocycloalkane
EP2885318A4 (en) PEPTIDE-DENDRIMER CONJUGATES AND USES THEREOF
EP2803932A4 (en) counting
GB2508701B (en) A knee-walker
HK1208495A1 (en) A novel paramyxovirus and uses thereof
GB201223264D0 (en) A hydrogen-storage-material
EP2838434A4 (en) MICRO BIOPSY DEVICE
GB2499126B (en) A banner
HK1210809A1 (en) Beta-hexosyl-transferases and uses thereof
GB201214242D0 (en) A device
PL2744571T3 (pl) Sposób hamowania adipogenezy za pomocą kompozycji zawierającej scirpusynę a i scirpusynę b i potencjał przeciwotyłościowy scirpusyny a i scirpusyny b
EP2822601A4 (en) MIRNA AND USES THEREOF
GB201201187D0 (en) A screen
GB2510464B (en) A Footgauge
AP2015008614A0 (en) Advertisement unit and a method thereof
SG10201508411UA (en) A rotor-arm assembly and a multi-rotorcraft
IL239166A0 (en) Advertising unit and method for it
GB2506132B (en) A fuseboard
GB201216855D0 (en) A sign
AU2012228V (en) GFLEUWHMTN Leucanthemum xsuperbum
GB201210209D0 (en) Moisturiser
ZA201208126B (en) A biodigester
GB201222541D0 (en) Kiddibidet and pottibidet
HK1166580A2 (en) A lacelock